STOCK TITAN

Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Paragon 28 (NYSE: FNA), a leading medical device company focused on the foot and ankle orthopedic market, has announced it will report its second quarter 2024 financial results on August 8, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time to discuss the results. Investors can join the call by dialing (833-470-1428) for domestic callers or (404-975-4839) for international callers, using conference ID: 389675.

Additionally, Paragon 28's management team will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on August 14, at 8:00 a.m. Eastern Time. Both events will be webcast live and archived on the company's investor relations website at ir.paragon28.com.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time.

Investors interested in listening to the conference call may do so by dialing (833-470-1428) for domestic callers or (404-975-4839) for international callers, using conference ID: 389675. Live audio of the webcast will be available on the “Investors” section of the Company’s website at: ir.paragon28.com. The webcast will be archived and available for replay for at least 90 days after the event.

Upcoming Conference Participation

Paragon 28 also announced the Company’s management team will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, at 8:00 a.m. Eastern Time / 6:00 a.m. Mountain Time. A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Matthew Brinckman

Senior Vice President, Strategy and Investor Relations

Phone: (720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

When will Paragon 28 (FNA) report its Q2 2024 financial results?

Paragon 28 (FNA) will report its second quarter 2024 financial results on August 8, 2024, after market close.

How can investors listen to Paragon 28's (FNA) Q2 2024 earnings call?

Investors can listen to Paragon 28's Q2 2024 earnings call by dialing (833-470-1428) for domestic callers or (404-975-4839) for international callers, using conference ID: 389675. The call begins at 4:30 p.m. Eastern Time on August 8, 2024.

Will Paragon 28 (FNA) participate in any upcoming investor conferences?

Yes, Paragon 28 (FNA) will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on August 14, 2024, at 8:00 a.m. Eastern Time.

Where can I find the webcast for Paragon 28's (FNA) earnings call and conference participation?

Live audio webcasts for both the earnings call and conference participation will be available on the 'Investors' section of Paragon 28's website at ir.paragon28.com.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

878.23M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD